Cerebrospinal fluid glutamate levels in chronic migraine

Cephalalgia

Volumn 24, Issue 9, 2004, Pages 735-739

  Peres, M F P ^a,b   Zukerman, E ^a   Senne Soares, C A ^a   Alonso, E O ^a   Santos, B F C ^a   Faulhaber, M H W ^a  

^a HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^b NONE   (Brazil)

Author keywords

Allodynia; Central sensitization; Chronic migraine; CSF; Fibromyalgia; Glutamate

Indexed keywords

ANALGESIC AGENT; ANTIMIGRAINE AGENT; CAFFEINE; DICLOFENAC; DIHYDROERGOTAMINE; DIPYRONE; GLUTAMIC ACID; ISOMETHEPTENE MUCATE; MEFENAMIC ACID; METOCLOPRAMIDE; NAPROXEN; NARATRIPTAN; NONSTEROID ANTIINFLAMMATORY AGENT; ORPHENADRINE; PARACETAMOL; RIZATRIPTAN; ZOLMITRIPTAN;

ADULT; ALLODYNIA; ARTICLE; CEREBROSPINAL FLUID; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBROMYALGIA; HEADACHE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MIGRAINE; PAIN ASSESSMENT; SENSITIZATION;

ADULT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHRONIC DISEASE; FEMALE; FIBROMYALGIA; GLUTAMIC ACID; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS;

EID: 4444264623     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2004.00750.x     Document Type: Article

References (28)

1. Ramadan NM. The link between glutamate and migraine. CNS Spectr 2003; 8:446-9.
2. Kavuk I, Yavuz A, Cetindere U, Agelink MW, Diener HC. Epidemiology of chronic daily headache. Eur J Med Res 2003; 8:236-40.
3. Terwindt GM, Ferrari MD, Tijhuis M, Groenen SM, Picavet HS, Launer LJ. The impact of migraine on quality of life in the general population: the GEM study. Neurology 2000; 55:624-9.
4. Lipton RB, Silberstein SD, Saper JR, Bigal ME, Goadsby PJ. Why headache treatment fails. Neurology 2003; 60:1064-70.
5. Silberstein SD, Lipton RB. Chronic daily headache. Curr Opin Neurol 2000; 13:277-83.
6. Feres MF, Young WB, Kaup AO, Zukerman E, Silberstein SD. Fibromyalgia is common in patients with transformed migraine. Neurology 2001; 57:1326-8.
7. Peres MF. Fibromyalgia, fatigue, and headache disorders. Curr Neurol Neurosci Report 2003; 3:97-103.
8. Zukerman E, Minatti-Hannuch SN, Mazzacoratti MGN, dos Reis Filho JB, Cavalheiro EA. Cerebrospinal fluid neurotransmitter amino acids in migraine. Cephalalgia 1993; 13 (Suppl 13):92.
9. Martinez F, Castillo J, Rodriguez JR, Leira R, Noya M. Neuroexcitatory amino acid levels in plasma and cerebrospinal fluid during migraine attacks. Cephalalgia 1993; 13:89-93.
10. Gallai V, Alberti A, Gallai B, Coppola F, Floridi A, Sarchielli P. Glutamate and nitric oxide pathway in chronic daily headache: evidence from cerebrospinal fluid. Cephalalgia 2003; 23:166-74.
11. Burstein R, Yarnitsky D, Goor-Aryeh I, Ransil BJ, Bajwa ZH. An association between migraine and cutaneous allodynia.nn. Neurol 2000; 47:614-24.
12. Arendt-Nielsen L, Graven-Nielsen T. Central sensitization in fibromyalgia and other musculoskeletal disorders. Curr Pain Headache Report 2003; 7:355-61.
13. Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headaches. field trial of revised IHS criteria. Neurology 1996; 47:871-5.
14. Mathew NT, Ravishankar K, Sanin LC. Coexistence of migraine and idiopathic intracranial hypertension without papilledema. Neurology 1996; 46:1226-30.
15. Quattrone A, Bono F, Oliveri RL, Gambardella A, Pirritano D et al. Cerebral venous thrombosis and isolated intracranial hypertension without papilledema in CDH. Neurology 2001; 57:31-6.
16. Wang SJ, Silberstein SD, Patterson S, Young WB. Idiopathic intracranial hypertension without papilledema: a case-control study in a headache center. Neurology 1998; 51:245-9.
17. Wolfe F, Smythe HA, Yunus MB et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33:160-72.
18. Cavalheiro EA, Fernandas MJ, Turski L, Naffah-Mazzacoratti MG. Spontaneous recurrent seizures in rats: amino acid and monoamine determination in the hippocampus. Epilepsia 1994; 35:1-11.
19. Ferrari MD, Odink J, Bos KD, Malessy MJ, Bruyn GW. Neuroexcitatory plasma amino acids are elevated in migraine. Neurology 1990; 40:1582-6.
20. D'Andrea G, Cananzi AR, Joseph R, Morra M, Zamberlan F, Ferro Milone F, et al. Platelet glycine, glutamate and aspartate in primary headache. Cephalalgia 1991; 11:197-200.
21. Cananzi AR, D'Andrea G, Perini F, Zamberlan F, Welch KM. Platelet and plasma levels of glutamate and glutamine in migraine with and without aura. Cephalalgia 1995; 15:132-5.
22. D'Eufemia P, Finocchiaro R, Lendvai D, Celli M, Viozzi L, Troiani P, et al. Erythrocyte and plasma levels of glutamate and aspartate in children affected by migraine. Cephalalgia 1997; 17:652-7.
23. Alam Z, Coombes N, Waring RH, Williams AC, Steventon GB. Plasma levels of neuroexcitatory amino acids in patients with migraine or tension headache. J Neurol Sci 1998; 156:102-6.
24. Rothrock JF, Mar KR, Yaksh TL, Goldbeck A, Moore AC. Cerebrospinal fluid analyses in migraine patients and controls. Cephalalgia 1995; 15:489-93.
25. Welch KM, Cutrer FM, Goadsby PJ. Migraine pathogenesis: Neural and vascular mechanisms. Neurology 2003; 60 Suppl 2:S9-S14.
26. Welch KM, D'andrea G, Tepley N, Barkley G, Ramadan NM. The concept of migraine as a state of central neuronal hyperexcitability. Neurol Clin 1990; 8:817-28.
27. Burstein R. Deconstructing migraine headache into peripheral and central sensitization. Pain 2001; 89:107-10.
28. Burstein R, Yamamura H, Malick A, Strassman AM. Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons. J Neurophysiol 1998; 79:964-82.